PL2229943T3 - Związek do zastosowania w leczeniu neuropatii obwodowych - Google Patents

Związek do zastosowania w leczeniu neuropatii obwodowych

Info

Publication number
PL2229943T3
PL2229943T3 PL10305260T PL10305260T PL2229943T3 PL 2229943 T3 PL2229943 T3 PL 2229943T3 PL 10305260 T PL10305260 T PL 10305260T PL 10305260 T PL10305260 T PL 10305260T PL 2229943 T3 PL2229943 T3 PL 2229943T3
Authority
PL
Poland
Prior art keywords
compounds
treatment
peripheral neuropathy
neuropathy
peripheral
Prior art date
Application number
PL10305260T
Other languages
English (en)
Inventor
Guern Marie-Emmanuelle Le
Marc Verleye
Jean-Marie Gillardin
Bernard Hublot
Original Assignee
Biocodex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocodex filed Critical Biocodex
Publication of PL2229943T3 publication Critical patent/PL2229943T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL10305260T 2009-03-19 2010-03-16 Związek do zastosowania w leczeniu neuropatii obwodowych PL2229943T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0951766A FR2943246B1 (fr) 2009-03-19 2009-03-19 Compose pour son utilisation dans le traitement des neuropathies peripheriques
EP10305260A EP2229943B1 (fr) 2009-03-19 2010-03-16 Composé pour son utilisation dans le traitement des neuropathies périphériques

Publications (1)

Publication Number Publication Date
PL2229943T3 true PL2229943T3 (pl) 2012-11-30

Family

ID=40940523

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10305260T PL2229943T3 (pl) 2009-03-19 2010-03-16 Związek do zastosowania w leczeniu neuropatii obwodowych

Country Status (8)

Country Link
US (1) US8927600B2 (pl)
EP (1) EP2229943B1 (pl)
CA (1) CA2696918C (pl)
DK (1) DK2229943T3 (pl)
ES (1) ES2391545T3 (pl)
FR (1) FR2943246B1 (pl)
PL (1) PL2229943T3 (pl)
PT (1) PT2229943E (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210052547A1 (en) 2016-02-15 2021-02-25 Institut National De La Sante Et De La Recherche Medicale (Nserm) Use of stiripentol and their derivatives for decreasing urinary oxalate concentration in an individual

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE795893A (fr) 1972-02-28 1973-06-18 Unicler Derives de (methylene dioxy-3,4 phenyl)-1 dimethyl-4,4 pentene-1, leur preparation et leur application en therrapeutique
PL376733A1 (pl) * 2002-11-01 2006-01-09 Takeda Pharmaceutical Company Limited Środek do zapobiegania lub leczenia neuropatii
US20050233010A1 (en) * 2004-04-19 2005-10-20 Satow Philip M Lithium combinations, and uses related thereto
FR2888748B1 (fr) * 2005-07-19 2007-10-12 Biocodex Composes neuroprotecteurs et compositions pharmaceutiques les comprenant
WO2009132119A2 (en) * 2008-04-25 2009-10-29 Auspex Pharmaceuticals, Inc. Substituted oxazolidinones
HUE043278T2 (hu) * 2008-09-05 2019-08-28 Gruenenthal Gmbh 3-(3-dimetilamino-1-etil-2-metil-propil)-fenolt és pregabalint vagy gabapentint tartalmazó gyógyszerkombináció

Also Published As

Publication number Publication date
DK2229943T3 (da) 2012-10-15
US8927600B2 (en) 2015-01-06
PT2229943E (pt) 2012-10-11
FR2943246B1 (fr) 2011-07-29
US20100240588A1 (en) 2010-09-23
EP2229943A1 (fr) 2010-09-22
EP2229943B1 (fr) 2012-07-04
ES2391545T3 (es) 2012-11-27
FR2943246A1 (fr) 2010-09-24
CA2696918C (fr) 2018-08-28
CA2696918A1 (fr) 2010-09-19

Similar Documents

Publication Publication Date Title
IL213619A0 (en) Treatment
GB0802116D0 (en) Treatment
GB0822011D0 (en) Treatment
ZA201201287B (en) Therapeutic aryl-amido-aryl compounds and their use
IL213761A0 (en) Novel ortho-aminoamides for the treatment of cancer
PH12013500022A1 (en) Surface treatment
EP2485853A4 (en) TREATMENT OF FLOORS
GB0811992D0 (en) Treatment
IL211189A0 (en) Compounds for the treatment of peripheral neuropathies
GB0822486D0 (en) Compounds for use in the treatment of pain
GB0900599D0 (en) Treatment
PL2534302T3 (pl) Kompozycja do obróbki powierzchni
IL210066A0 (en) Novel ortho-aminoanilides for the treatment of cancer
GB201207179D0 (en) Container Treatment
GB0902173D0 (en) Compounds and their use
GB0901465D0 (en) Compounds for use in therapy
GB0913968D0 (en) Treatment
GB201016486D0 (en) Compounds for the use in treatment of plants
PL2263454T3 (pl) Kompozycja uzdatniająca
GB201001521D0 (en) Treatment
GB0820972D0 (en) Treatment
PL2229943T3 (pl) Związek do zastosowania w leczeniu neuropatii obwodowych
GB0805912D0 (en) Treatment
GB2469791B (en) Transmucosal formulation of compounds providing dihydroartemesinin for use in the treatment of neoplastic disease
GB0809319D0 (en) The treatment of puritus